Swiss National Bank Aerie Pharmaceuticals Inc Transaction History

Swiss National Bank

$150 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$6.37 - $15.23 $7,644 - $18,276	1,200 Added 1.17%	103,800 $1.57 Million
Q2 2022 Aug 09, 2022	SELL	$4.95 - $9.16 $18,315 - $33,892	-3,700 Reduced 3.48%	102,600 $770,000
Q1 2022 May 09, 2022	BUY	$5.64 - $9.8 $46,812 - $81,340	8,300 Added 8.47%	106,300 $967,000
Q2 2021 Aug 06, 2021	BUY	$15.16 - $18.97 $106,120 - $132,790	7,000 Added 7.69%	98,000 $1.57 Million
Q1 2021 May 07, 2021	BUY	$13.12 - $20.9 $20,992 - $33,440	1,600 Added 1.79%	91,000 $1.63 Million
Q4 2020 Feb 05, 2021	BUY	$9.12 - $14.49 $11,855 - $18,837	1,300 Added 1.48%	89,400 $1.21 Million
Q2 2020 Aug 05, 2020	BUY	$12.0 - $16.13 $34,800 - $46,777	2,900 Added 3.4%	88,100 $1.3 Million
Q1 2020 May 08, 2020	BUY	$11.84 - $25.52 $20,128 - $43,384	1,700 Added 2.04%	85,200 $1.15 Million
Q4 2019 Feb 06, 2020	BUY	$17.72 - $25.1 $28,352 - $40,160	1,600 Added 1.95%	83,500 $2.02 Million
Q3 2019 Nov 12, 2019	BUY	$18.41 - $28.0 $27,615 - $42,000	1,500 Added 1.87%	81,900 $1.57 Million
Q2 2019 Aug 02, 2019	BUY	$28.97 - $48.21 $170,923 - $284,439	5,900 Added 7.92%	80,400 $2.38 Million
Q1 2019 May 10, 2019	BUY	$36.32 - $49.25 $90,800 - $123,125	2,500 Added 3.47%	74,500 $3.54 Million
Q4 2018 Feb 13, 2019	BUY	$33.0 - $60.04 $330,000 - $600,400	10,000 Added 16.13%	72,000 $2.6 Million
Q3 2018 Nov 08, 2018	BUY	$56.15 - $73.9 $162,835 - $214,310	2,900 Added 4.91%	62,000 $3.82 Million
Q2 2018 Aug 09, 2018	BUY	$47.85 - $70.45 $248,820 - $366,340	5,200 Added 9.65%	59,100 $3.99 Million
Q1 2018 May 04, 2018	BUY	$51.15 - $61.0 $66,495 - $79,300	1,300 Added 2.47%	53,900 $2.92 Million
Q4 2017 Feb 07, 2018	BUY	$50.85 - $65.1 $116,955 - $149,730	2,300 Added 4.57%	52,600 $3.14 Million
Q3 2017 Nov 03, 2017	BUY	$48.6 - $60.1 $2.44 Million - $3.02 Million	50,300	50,300 $2.45 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account